Inventor · Franklin Lakes, NJ, US

Arnold Lippa

14Patents
12h-index
7Co-inventors
71Inventor score

Filing activity: Sep 17, 1985 → Jun 2, 2013

Most-cited inventions

PatentTitleAreaCited byStatus
US4777128A Fluorescence immunoassay involving energy transfer between two fluorophores Emerging Cross-Sectional Technologies 85 Expired
US6169813A Frequency transpositional hearing aid with single sideband modulation Electricity 68 Expired
US6173062A Frequency transpositional hearing aid with digital and single sideband modulation Electricity 64 Expired
US6377693B1 Tinnitus masking using ultrasonic signals Human Necessities 64 Expired
US6162463A Extended release formulation of diltiazem hydrochloride Human Necessities 34 Expired
US6372919B1 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent Chemistry; Metallurgy 33 Expired
US6569887B2 (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake Chemistry; Metallurgy 18 Expired
US6716868B2 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Chemistry; Metallurgy 17 Expired
US7098229B2 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof Chemistry; Metallurgy 16 Expired
US7081471B2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Chemistry; Metallurgy 14 Expired
US7041835B2 (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Chemistry; Metallurgy 13 Expired
US7098230B2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Chemistry; Metallurgy 13 Expired
US4857514A Virus inactivation Human Necessities 4 Expired
US9393204B2 Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.